Genomic Vision Appoints David Del Bourgo as Head of Sales and Marketing

Posted on by

With an MBA from the University of Chicago (2006) and an MSc from the Compigne University of Technology (1997), David Del Bourgo has combined education in management and biomedical engineering. He has acquired 17 years of experience in marketing and sales development within the healthcare industry.

Before joining Genomic Vision, David Del Bourgo was VP Sales and Marketing at Theraclion, which specializes in therapeutic ultrasound equipment. After joining the company in 2009, he instigated Theraclions marketing strategy, developed the network of key opinion leaders and deployed the direct and indirect sales of an innovative echotherapy solution, which established the company as a major player in the treatment of tumors by ultrasound.

From 2006 to 2009, David was Director of Corporate Development and Marketing at Orbotech, a NASDAQ-listed Israeli electronics company, where he notably contributed to the growth of their medical division and led the acquisition of a Danish company specializing in nuclear cardiology (turnover of $30 million). His other positions have included Manager in Strategic Consulting at Advention Business Partners (2005-2006) and various positions at General Electric Healthcare, where he was initially a researcher (1997) before being appointed International Product Marketing Manager (2001-2003).

At Genomic Vision, Davids mission has begun with the setting up of a Sales and Marketing team, which is already operational, consisting of product specialists and a field team whose aim will be to promote the Companys innovative genetic tests among the main European diagnostic centers.

Aaron Bensimon, Genomic Visions co-founder and Chairman, says: We are very pleased to be able to count on a manager with such experience at Genomic Vision. David and his team are highly driven by their objective of deploying our international marketing strategy. His expertise and knowledge of the sector represent real assets in identifying sales opportunities for the genetic tests we are developing, and notably those targeting breast and colon cancer, which are scheduled to be launched in 2015.

Next financial press release

ABOUT GENOMIC VISION A spinoffof the Institut Pasteur, Genomic Vision is a molecular diagnostics company specialized in developing diagnostic tests for genetic diseases and cancers. Using molecular combing, an innovative technology that allows the direct visualization of individual DNA molecules, Genomic Vision detects quantitative and qualitative variations in the genome that are at the origin of numerous serious pathologies. Having benefited from the financial support of the Institut Pasteur, SGAM AI, Vesalius Biocapital and Quest Diagnostics, the Company is developing a solid portfolio of tests that notably target breast cancer and cancer of the colon. Since 2013, the Company has marketed the CombHeliX FSHD test for identifying a myopathy that is difficult to detect, Facio-scapulo-humeral dystrophy (FSHD), in the United States thanks to a strategic alliance with Quest Diagnostics, the American leader in diagnostic laboratory tests, and in France.

ABOUT MOLECULAR COMBING DNA molecular combing technology considerably improves the structural and functional analysis of DNA molecules. DNA fibers are stretched out on glass slides, as if combed, and uniformly aligned over the whole surface. It is then possible to identify genetic anomalies by locating genes or specific sequences in a patients genome using genetic markers, an approach developed by Genomic Vision and patented under the name Genomic Morse Code. This exploration of the entire genome at high resolution via a simple analysis enables the direct visualization of genetic anomalies that are undetectable by other technologies.

For further information, please go to http://www.genomicvision.com

Read more:

Genomic Vision Appoints David Del Bourgo as Head of Sales and Marketing

UCLA Stem Cell Researchers Announce Gene Therapy Cure for 18 Bubble Baby Patients – Video

Posted on by


UCLA Stem Cell Researchers Announce Gene Therapy Cure for 18 Bubble Baby Patients
Researchers at UCLA announced today that they had cured 18 children who were born with the so-called Bubble Baby disease, a genetic disorder that leaves the young sufferers without a working...

By: UCLA Eli Edythe Broad Center of Regenerative Medicine and Stem Cell Research

Read this article:

UCLA Stem Cell Researchers Announce Gene Therapy Cure for 18 Bubble Baby Patients - Video

The promise and potential dangers of gene therapy | Tomorrow Today – Interview – Video

Posted on by


The promise and potential dangers of gene therapy | Tomorrow Today - Interview
What role is gene therapy likely to play in the future? Professor Wolfgang Uckert, the president of the German Society for Gene Therapy, talks about the potential of the treatment. More tomorrow-...

By: DW (English)

View original post here:

The promise and potential dangers of gene therapy | Tomorrow Today - Interview - Video

New Stem Cell Treatment Found To Cure 'Bubble Baby' Disease

Posted on by

Chuck Bednar for redOrbit.com Your Universe Online

A new stem cell gene therapy developed by researchers at UCLA is set to begin clinical trials early next year after the technique reportedly cured 18 children who were born without working immune systems due to a condition known as ADA-deficient Severe Combined Immunodeficiency (SCID) or Bubble Baby disease.

The treatment was developed by Dr. Donald Kohn, a member of the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, and his colleagues, and according to the university, it is able to identify and correct faulty genes by using the DNA of the youngsters born with this life-threatening condition.

Left untreated, ADA-deficient SCID is often fatal within the first year of a childs life, reports Peter M. Bracke for UCLA. However, after more than three decades of research, Dr. Kohns team managed to develop a gene therapy that can safely restore the immune systems of children with the disease by using their own cells and with no noticeable side effects.

All of the children with SCID that I have treated in these stem cell clinical trials would have died in a year or less without this gene therapy, instead they are all thriving with fully functioning immune systems, Dr. Kohn, who is also a professor of pediatrics and of microbiology, immunology and molecular genetics, said in a recent statement.

Children born with SCID have to be isolated in a controlled environment for their own safety, because without an immune system, they are extremely vulnerable to illnesses and infections that could be deadly. While there are other treatments for ADA-deficient SCID, Dr. Kohn noted that they are not always optimal or feasible for many children. The new technique, however, provides them with a cure, and the chance to live a full healthy life.

SCID is an inherited immunodeficiency that is typically diagnosed about six months after birth, the researchers said, and children with the condition are so vulnerable to infectious diseases that even the common cold could prove fatal to them. This particular form of the condition causes cells to not create ADA, an enzyme essential for the production of the white blood cells which are a vital component of a healthy, normally-functioning immune system.

Approximately 15 percent of all SCID patients are ADA-deficient, according to the university, and these youngsters are typically treated by being injected twice per week with the required enzyme. This is a process that must continue throughout a patients entire life, and even then it doesnt always work to bring their immune systems to optimal levels. Alternately, they could undergo bone marrow transplants from matched siblings, but those matches are rare and the transplanted cells themselves are often rejected by the childs body.

Dr. Kohn and his colleagues tested two therapy regimens on 18 ADA-deficient SCID over the course of two multi-year clinical trials starting in 2009. During the trials, the blood stem cells of the patients were removed from their bone marrow and genetically modified in order to correct the defect. All 18 of the patients were cured.

The technique used a virus delivery system first developed in Dr. Kohns laboratory in the 1990s a technique which inserts the corrected gene that produces the ADA into the blood forming stem cells in the bone marrow. The genetically corrected blood-forming stem cells will then produce the T-cells required to combat infections.

See the rest here:

New Stem Cell Treatment Found To Cure 'Bubble Baby' Disease

Health Beat: Gene therapy: From bench to bedside: Hemophilia

Posted on by

ORLANDO, Fla. -

Little Hunter Miller's motor is always running. Like most toddlers, he's sometimes one step away from trouble, but for Hunter, being rough and tumble can have serious side effects. Hunter has severe hemophilia.

Three days after he was born, a routine circumcision caused a major scare.

"You know, a baby gets up in the morning and their diapers are just full," said Hunter's grandmother, Tina Miller. "Well, his was full, but it was full of blood."

Doctors diagnosed Hunter with hemophilia A, which means his blood is missing a protein, known as clotting factor VIII. When he gets hurt, doctors need to inject the clotting factor to stop the bleeding. He's had eight emergency room visits in 19 months.

"Him falling, bumping his head too hard, little cuts. He cut the roof of his mouth with a tortilla chip and that was a hospital trip," said Heather Frederick, Hunter's mother.

Dr. Katherine Ponder studies gene therapy treatment for hemophilia and other blood disorders. Her lab treated hemophilia A in animals, but she said the therapy isn't quite ready for humans yet.

"I think that the big question is going to be the safety," said Katherine Ponder, hematologist at Washington University School of Medicine in St. Louis.

But gene therapy has proven effective for some patients with hemophilia B. Researchers at St. Jude's Children's Research Hospital and University College of London have added the missing protein -- factor IX -- to a specially-engineered virus, which travels to the patients liver and transfers the gene.

"This modifies the disease from a situation where they might bleed once a week to a situation where they hardly ever bleed," Ponder explained.

Here is the original post:

Health Beat: Gene therapy: From bench to bedside: Hemophilia

10 Game-Changing Technologies to Transform the World in 2015

Posted on by

New York, NY (PRWEB) November 25, 2014

If only I could see what you see. So says Dr. Watson to Sherlock Holmes (in Steven Deitzs adaptation of Sherlock Holmes: The Final Adventure,) to which Holmes replies, Oh you see, Watsonbut you do not observe.

Most people view Sherlock Holmes as a Detective, in this day and age, however, Holmes' words might very well be that of a Futurist. Global futurist Jack Uldrich, often finds himself sharing similar sentiments with his clients. As a futurist, Uldrich is in fact a bit of a detective; he researches, writes and speaks on future trends to a number of clients in a variety of industries including energy, agriculture, manufacturing, finance and healthcare all over the world.

At this time of year, in addition to wrapping up his engagements on the speaking circuit, his focus is set upon sleuthing out the imminent technological trends for the New Year.

"In the past year we have witnessed a series of startling advances. And from the looks of it, 2015 is going to alter the game even further, as far as technological changes are concerned," says Uldrich.

10 Game Changing Technologies Poised to Transform the World in 2015, Uldrichs latest article, includes predictions that run the gamut from healthcare advances such as genomic surgery, a nicotine vaccine and rapid diagnostics, to architectural feats such as 3D printed houses. Also among his predictions for the coming year, he states that a cure for Type 1 Diabetes, a disease that costs the U.S. health care system an estimated $15 billion every year, is even within the realm of possibility. Each development is an extraordinary advance and each heralds a brighter future.

The complete elimination of diabetes, smoking or genetic diseases will not, however, occur overnight. Nor will a world of clean and affordable energy, abundant freshwater, 3D printed houses or worldwide high-speed Internet access miraculously appear by the end of 2015."

While nothing about the advances we will see in 2015 according to Uldrich are "Elementary" --"the Game is definitely afoot."

Parties interested in learning more about him, his books, his daily blog or his speaking availability are encouraged to visit his website. Media wishing to know more about either the event or interviewing Jack as a futurist or trend expert can contact Amy Tomczyk at (651) 343.0660.

View post:

10 Game-Changing Technologies to Transform the World in 2015

Intel futurist: 'imagination is the undeveloped skill'

Posted on by

Brian David Johnson was the first futurist to work at Intel. It takes around 10-15 years to design, build and deploy a new chip, he tells the audience at WIRED Retail, which is why Intel needs someone who can look 10-15 years into the future and tell them what the world they are designing for will be like.

"The work that I do is very pragmatic," Johnson says. "I am judged on my ability to tell people what is coming." He also, however, has to give them information that will allow them to do something about it.

The pictures of what the future will look like usually offer a streamlined, minimalist and almost sterile vision of life. Of these kind of pictures, Johnson says he finds them "at best intellectually dishonest -- at worst it's insulting".

"Where are things? Where is stuff that makes us comfortable?" We are complex beings with many needs, he points out. "We have different cultures and different beliefs that make us interesting."

"Let's design futures that are designed for real people, and the futures of real people," Johnson says.

In accordance with Moore's Law, as we approach to year 2020, the size of the chip will begin to approach zero. We are already approaching five nanometres, which means theoretically we could turn anything into a computer. This knowledge changes the questions we have to ask ourselves, says Johnson. "I believe this unbinds our businesses and unbinds retail."

In 2024 as meaningful computational power approaches zero, something really interesting will happen to devices: they will disappear. The importance of screens to devices overall will decline, and yet they will remain important to consumers. They will continue to be, he says, "the windows through which we shop, through which we buy through which we communicate." Fellow WIRED Retail speaker Tracy Yaverbaun probably agrees. But increasingly retail will be based on data interactions between retailers and customers. Retailers will need to think how they will make these interactions meaningful and what their brands will be like in this data-driven online world.

Ultimately retail and shopping is about people and brands need to keep thinking how it will solve a problem for them, says Johnson. "If we set that as a goal we can do really really interesting things."

"We are living in a really interesting time right now. We are surrounded by computational intelligence." We're at a time right now, he continues, where science and technology have improved to the point where what we build is only contained by the limits of our imaginations. We are being held back, he says, by "our inability to imagine a far more awesome future that we are going to have" and that "our imagination is the one skill that is not developed".

"If we have a vision for the future of retail, how do we change it?" he asks. The answer: "We change the story people tell themselves about the future they live in." If you can change the story, people will make different decisions.

See the original post:

Intel futurist: 'imagination is the undeveloped skill'

Religious Freedom: "The law that let us practice our spirituality came too late." – Crouser #2/4 – Video

Posted on by


Religious Freedom: "The law that let us practice our spirituality came too late." - Crouser #2/4
"Even though everyone says they #39;re not racist any more, that #39;s probably one of the biggest things they pay attention to." In September of 2014, the Your Fellow Americans team visited the...

By: YFAmericans

More here:

Religious Freedom: "The law that let us practice our spirituality came too late." - Crouser #2/4 - Video

RevolveR – at Brewster Corpus Christi – Performing Freedom & Killing in the Name – Video

Posted on by


RevolveR - at Brewster Corpus Christi - Performing Freedom Killing in the Name
RevolveR is a houston base Rage Against The Machine tribute. For Inquiries here #39;s the link of their facebook page https://www.facebook.com/RevolverRATMtribute.

By: brandorn

Visit link:

RevolveR - at Brewster Corpus Christi - Performing Freedom & Killing in the Name - Video